Bio Protocol (BIO) climbed roughly 19% in 24 hours to trade near $0.040. The token ranked fourth on CoinGecko's trending list and logged $137M in daily volume against a $86M market cap.
A Volume-to-Cap Ratio That Stands Out
The daily volume-to-market-cap ratio for BIO sits above 1.5. That means more dollar value changed hands in 24 hours than the entire token supply is worth at current prices. Ratios above 1.0 often reflect speculative short-term activity. The token's market cap rank sits at 320 on CoinGecko. Despite the rank, the volume figure places BIO among the most actively traded assets in the scan window.
Ethereum (ETH), by comparison, logged a volume-to-cap ratio well below 0.10 in the same period. That contrast frames the outsized short-term attention BIO is receiving relative to its size.
Also Read: Ultima Token Posts $11.4M Daily Volume As Price Holds Near $2,965
What Bio Protocol Does
Bio Protocol describes itself as a decentralized science, or DeSci, coordination layer. The protocol pools funding and governance across biotech research projects. Token holders can participate in directing capital toward specific research pipelines.
Each pipeline operates as a sub-DAO within the broader Bio Protocol system.
The project sits in a niche that intersects two active crypto narratives. DeSci advocates argue that blockchain-based funding removes traditional gatekeepers from scientific research. Separately, the AI-and-biotech crossover has attracted speculative capital in 2025 and early 2026. Bio Protocol's positioning overlaps with both themes. That overlap may partly explain the spike in search activity and volume.
Also Read: TAO At $257: Bittensor's Decentralized AI Market Keeps Traders Watching
Background
Bio Protocol launched its token in late 2024. The initial listing generated significant early trading volume. The token dropped sharply from its post-launch highs through the first quarter of 2025 as broader risk appetite contracted.
By late 2025, several DeSci projects including Bio Protocol saw renewed interest as the sector attracted venture attention from funds focused on AI-adjacent biotech applications. Bio Protocol's current price near $0.040 remains well below its all-time highs.
The project has maintained active development through that period, publishing governance updates and expanding its sub-DAO count.
Also Read: Monad Posts Mild Decline But Holds $327M Cap As Developer Activity Builds
What the Data Does Not Confirm
CoinGecko trending placement reflects search and watchlist activity on the platform. It does not confirm a sustained price trend or fundamental catalyst. No protocol announcement or partnership was identified in this scan window to explain the 19% move. Tokens can spike onto trending lists from coordinated social activity or exchange listing speculation without underlying news. Traders should note that BIO's market cap of $86M means even modest buy pressure can produce outsized percentage moves.
The BTC-denominated 24-hour change for BIO was approximately plus 20.8%, meaning the gain outpaced Bitcoin's own price movement in the same period. That relative outperformance is what pushed the token into prominent trending placement.
Read Next: LayerZero’s ZRO Token Sees $36.5M Volume As Cross-Chain Narrative Builds